The antioxidants, vitamin A and E but not vitamin C and melatonin enhance the proapoptotic effects of irinotecan in cancer cells in vitro
-
Add time:09/05/2019 Source:sciencedirect.com
Irinotecan is one of the camptothecin analog which has been shown to have a broad spectrum of antitumor activities against various malignancies. The aim of this study was to evaluate the effect of vitamin A, C, E and melatonin on proapoptotic activity of irinotecan in human cancer cells in vitro. We observed that irinotecan induced apoptosis in all types of analyzed cell lines when used as a single agent. Combination of selected antioxidants with various doses of irinotecan (7.5–60 μM) resulted in significant increase in apoptotic cell death in A549 and HT29 cancer cell lines. The highest killing efficiency was observed after co-incubation of the cells with irinotecan and vitamin A (10 μM), or vitamin E (25 μM), respectively. The addition of vitamin C and melatonin to irinotecan treatment did not promote increase in killing of cancer cells. Our results indicate that some antioxidants can enhance the proapoptoic activity (properties) of irinotecan in human cancer cells in vitro. These findings may be supportive for the optimization of therapeutic efficacy of irinotecan treatment.
We also recommend Trading Suppliers and Manufacturers of Irinotecan hydrochloride trihydrate (cas 136572-09-3). Pls Click Website Link as below: cas 136572-09-3 suppliers
Prev:Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial
Next:Interaction of L-myc oncogene in breast cancer with irinotecan onto functionalized magnetic nanoparticles) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Special CommunicationTransarterial Treatment of Colorectal Cancer Liver Metastases with Irinotecan-Loaded Drug-Eluting Beads: Technical Recommendations09/10/2019
- Genotoxic effects of irinotecan combined with the novel platinum(II) complexes in human cancer cells09/09/2019
- Rational design of polysorbate 80 stabilized human serum albumin nanoparticles tailored for high drug loading and entrapment of irinotecan09/08/2019
- Synthesis, metabolite analysis, and in vivo evaluation of [11C]irinotecan as a novel positron emission tomography (PET) probe09/07/2019
- Interaction of L-myc oncogene in breast cancer with irinotecan onto functionalized magnetic nanoparticles09/06/2019
- Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial09/04/2019
- Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats09/03/2019
-
Health and Chemical more >


